Instructions for Authors
All manuscripts must be submitted online via Editorial Manager at
JBJS Journal of Orthopaedics for Physician Assistants (JBJS JOPA) is a peer-reviewed publication that publishes timely and practical articles covering all orthopaedic subspecialties for Physician Assistants (PAs) and Nurse Practitioners (NPs). JBJS JOPA provides a unique forum for health-care practitioners to share knowledge and experiences with colleagues in the profession. Authors are encouraged to contribute any original articles that promote PA and NP orthopaedic education.
Articles submitted to JBJS JOPA undergo double-blinded peer review by a panel of orthopaedic physicians and PAs to ensure accuracy, clinical relevance, and readability.
Conditions for Submission
What to Expect After Submission
Public Access Policy
Embargo Policy for Accepted Manuscripts
CONDITIONS FOR SUBMISSION
- Articles are accepted for exclusive publication in JBJS JOPA. Previously published articles, including those published in non-English-language journals, are not accepted.
- Physical and electronic copies of published articles and illustrations become the property of The Journal of Bone and Joint Surgery, Inc.
- All manuscripts must follow the guidelines outlined in our
All manuscripts must be submitted, as a Microsoft Word file, through Editorial Manager (a web-based service). Corresponding authors must register via http://www.editorialmanager.com/jopajbjs and will then receive an e-mail containing a Username and Password that will allow access for manuscript submission.
JBJS JOPA accepts reviews of orthopaedic topics, case studies, articles on professional issues and experiences, and videos. Please refer to the
Article Type Definitions for full descriptions of each and use the correct definition to classify your article on submission.
The following items must be submitted for all article types (excluding stand-alone videos):
- Title Page including (1) article title, (2) authors' names, in order in which they should appear, and academic degrees, (3) practice or institution (and city and state or country) with which each author is affiliated, (4) corresponding author and his/her e-mail address.
- Manuscript Text: See "Manuscript Structure" below.
- Copyright Transfer and Author Agreement: All authors must sign a Copyright Transfer and Author Agreement granting JBJS JOPA exclusive copyright to all material, except for previously copyrighted items (see #5 below) and video. Authors can maintain the copyright to videos but must complete the Video License Agreement granting JBJS JOPA unlimited license to use the video online.
- Disclosure of Potential Conflicts of Interest: Authors must complete an ICMJE Conflict of Interest Statement form for each submitted manuscript. As this form will not load properly when opened through a browser or email client, download the PDF file directly to your computer and open with Adobe Acrobat or Reader. Scanned copies of the completed form are not acceptable. JBJS JOPA will post the forms online and summarize them in a statement in the article. The ICMJE forms have no bearing on the decision to accept a manuscript.
- Permission to Use Figures, Tables, and Videos Owned by Another Party: Authors are responsible for obtaining permissions. Provide (1) a full citation for the previous publication and (2) a letter from the owner of the copyright granting permission for JBJS JOPA to reproduce the copyrighted material OR a completed permissions form stating the date when permission was requested and the approximate date when the permission is expected to be received.
Written manuscripts must be submitted as a Microsoft Word file and contain a minimum of 1,200 words, including the Abstract but excluding references and figure legends. Manuscripts not meeting these specifications will be returned for modification.
Stand-alone physical examination or injection technique video submissions do not require a written abstract and can be submitted through Editorial Manager by entering in the video title and authors on the site and uploading a link to the video. All video files must be uploaded to the Video Submissions Site according to our Author Video Guidelines. Instructions for upload can be found here.
All other JBJS JOPA articles should consist of:
- A brief, bullet-pointed Abstract of no more than 100 words that summarizes the key points of the article.
- The body:
- Reviews: Use appropriate headings and subheadings to organize paragraphs.
- Case Studies: Provide a "Case Study" section describing the clinical presentation, history, treatment, and outcomes for a given patient and a "Discussion" section containing learning points based on the case. All case studies must also include a statement that each patient was informed that data concerning the case would be submitted for publication and that each patient agreed, either verbally or in writing.
- Professional Issues and Experiences: This can be a free-form narrative.
- Reviews and case studies should contain a reference section, in PubMed/Index Medicus format, after the manuscript text. Number the references according to the order of citation in the text (not alphabetically), and cite all references in the text.
- Figure legends must be included at the end of the manuscript text file, after the reference section, for all images. Explain what each figure shows. Define all arrows and other such indicators appearing on the figure.
- Figures must be submitted in TIFF or EPS format. Cite all figures, in order, in the text. See Guidelines for Figures for detailed instructions.
- JBJS JOPA welcomes submission from PAs, NPs, and allied health professionals such as physical therapists and athletic trainers. In addition, supervising physicians are encouraged to submit articles on topics in their subspecialty or issues related to the PA profession or on a procedure or service unique to their practice.
- Each author must have contributed significantly to, and be willing to take public responsibility for, the work being submitted. All authors must have been actively involved in the drafting and critical revision of the manuscript, and each must provide final approval of the version to be published.
- Individuals who have contributed to only one section of the manuscript or have contributed only cases should be credited in an acknowledgment footnote. See the ICMJE
author definitions page for additional guidance regarding authors and non-author contributors.
- A non-author writer who is employed by a commercial organization must be mentioned, along with the name of his or her employer, in an acknowledgment footnote. The non-author writer must also submit a Conflict of Interest Statement.
- The order of names reflects only the preference of the authors. Any change in authorship (including the order of names and the designation of the corresponding author) after the initial review process necessitates a signed letter, from all authors, agreeing to the change.
WHAT TO EXPECT AFTER SUBMISSION
- Manuscripts are generally evaluated by the JBJS JOPA editorial staff and assigned to the Editor, who will then generally send the paper to consultant reviewers.
- If a reviewer or handling editor has a conflict of interest regarding the subject matter of a manuscript, he/she discloses this to the Editor, who makes the final decision regarding acceptance or rejection of the manuscript. The Editor has no known conflicts or competing interests.
- The corresponding author is informed of the publication date of an accepted manuscript approximately 3 weeks before publication.
PUBLIC ACCESS POLICY
To enable authors to comply with the requirements of outside funding bodies, JBJS, Inc. will deposit, into the PubMed Central (PMC) Archive, the final published version of any article funded by a body requiring such deposit. Thus, authors should identify on the Copyright Transfer Agreement (CTA) whether their article is based on research funded in whole or in part by the National Institutes of Health (NIH), Howard Hughes Medical Institute (HHMI), Wellcome Trust, Research Councils UK (RCUK), or another funding agency requiring deposit to a repository. JBJS, Inc., as a service to its authors, will then identify these articles to the National Library of Medicine (NLM) and transmit them to PMC. PMC will make these articles freely available after an embargo period that satisfies the funding agency's requirements (or immediately upon publication if the author chose the open-access option). JBJS, Inc. will not be held responsible for retroactive deposits to PMC if the author has not identified the funding agency on the CTA form.
JBJS, Inc. offers an open-access option to authors who want readers around the globe to have free, perpetual, unrestricted online access to their article on the JBJS JOPA web site immediately upon publication. Authors are offered this option after their article has been accepted for publication to ensure that their choice has no influence on the peer-review or acceptance process. All articles submitted to JBJS JOPA are subjected to our standard peer-review process and are accepted or rejected on the basis of their merit only.
Authors retain copyright for all articles published with the open-access option. Authors grant JBJS, Inc. and its publishing partner Wolters Kluwer the exclusive license to publish the article and to identify themselves as the original publisher. The
Wolters Kluwer Open Access License Agreement (the "Open Access License") supersedes and replaces Section 1.a of the JBJS JOPA Copyright Transfer and Author Agreement signed by authors (on manuscript submission), for authors who later choose the open-access option (on acceptance). Open-access articles are published under the terms of the standard
Creative Commons Attribution‐NonCommercial-NoDerivatives International (CC BY-NC-ND) license, or, if mandated by the authors' funding body, the Creative Commons Attribution International (CC BY) license, both of which permit copying and redistribution of the material in any medium or format.
The article processing charge for the open-access option is $2,200 (CC BY-NC-ND license) or $2,740 (CC BY license, which is offered only to authors who have received funding that mandates the CC BY license). The publication fee is charged on acceptance of the article and must be paid in full within 30 days by credit card by the author, funding agency, or institution.
For more information, please see our FAQs.
EMBARGO POLICY FOR ACCEPTED MANUSCRIPTS
Information concerning or contained in your article (including its status—i.e., accepted, under review, etc.) cannot be discussed with the media, published, broadcast, posted online, or otherwise placed in the public domain until after the publication date of the issue. It is the responsibility of the corresponding author to ensure that all coauthors are aware of this policy. See our
Confidentiality and Embargo Policy for additional information regarding this policy.
An author who wishes to appeal a decision should contact email@example.com with a detailed letter that explains the reason for the appeal within one month of the final decision date. This letter will be considered by the Editor, and the author will be notified of the outcome. Decisions on appeals are final, without exception. Priority is given to new submissions, so the appeal process may take longer than the original submission process.
Guidelines for Figures
Author Video Guidelines
Confidentiality and Embargo Policy
Hybrid Open-Access FAQ
Copyright Transfer Form
Conflict of Interest Form (must be downloaded and completed using Adobe Acrobat or Reader)
Video License Agreement
Figure Permissions Form
Open Access License Agreement (open-access option only)